Nov. 13, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading live biotherapeutics company, today reported third quarter 2024 financial results and ...
Seres Therapeutics Inc. (MCRB) on Wednesday reported third-quarter earnings of $88.8 million. The Cambridge, Massachusetts-based company said it had profit of 58 cents per share. Losses, adjusted to ...
Salarius Pharmaceuticals Inc (SLRX) is expected to report for 3Q. Seres Therapeutics Inc (MCRB) is expected to report $-0.08 for 3Q. Sonida Senior Living Corp (SNDA) is expected to report $-0.18 for ...
Vertex Inc. (NASDAQ:VERX) ("Vertex” or the "Company”), a global provider of tax technology solutions, announced a new survey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback